My 2 cents on the Amarex settlement. Although I submitted

New Post Public Reply Private Reply Replies (2) Message Board
Jake2212
1,546
My 2 cents on the Amarex settlement. Although I submitted several posts on the Amarex arbitration in the summer of '23 and the fall of '22, I resisted suggestions to opine on the likely eventual recovery because I didn't know what I didn't know. With CYDY's press release today, I can offer a few thoughts (perhaps semi educated guesses) on what may have driven the end result.

The payment terms, 10 million immediately, and 2 additional million within a year, suggest a possible scenario where the 10 million comprises all or most of the policy limits on an Amarex malpractice insurance policy, and the 2 million is being contributed by NSF to make the deal happen in order to protect Amarex from bankruptcy and NSF from its own potential liability in the event the arbitrator would have awarded consequential or punitive damages and pierced NSF's corporate veil.

Like many others, I expected a settlement, but I was always very skeptical of predictions of $50-100 million recoveries because I couldn't imagine why Amarex would pay premiums for that much coverage when its standard service agreement, drafted by its own attorneys, contained a provision eliminaiting liability and damages for consequential (lost profits) and punitive damages. Under such circumstances, carrying $10 million of coverage might still have seemed needlessly excessive.

So why would Amarex have purchased $10 million of coverage if lost profits were off the table, why would its greedy insurance carrier agree to fork over the policy limits, and why would Amarex throw in $2 million more? Perhaps the answer is suggested by the holding in the Aldloo case, cited in my post #130113, Nov 3, 2022, in which the court held that a limitation of liability provision would not be enforceable, on grounds of public policy, if the involved conduct was willful, intentional, or grossly negligent.

I don't know if the arbitrator or an assigned mediator conducted the settlement negotiations here, but, based on quite a bit of past experience with high stakes mediations, I would expect the mediator/arbitrator dangled the enforcement of the limit of liability provision vs unenforceability on public policy grounds in front of the opposing attorneys as equally possible outcomes for them to consider. Consequential damages, assuming SA could overcome Amarex's contention that calculating lost profits would be speculative, would have likely well exceeded $100 million. But to actually collect such an award, SA would have had to pierce the corporate veil shielding NSF, no easy task. (I'm guessing that the arbitrator was also keeping the parties in doubt regarding his/her likely ruling the corporate veil issue.)

If my guesswork above is anywhere in the ball park, CYDY and SA were dealing with an upcoming hearing in November in which they would have had to prevail on the consequential damages issue to leverage the judgment proof Amerex's insurance coverage (probably $10 million, but certainly not much more than that), but then also prevail on the corporate veil issue against NSF to recover all its lost profits, i.e. >$100 million.

Under the circumstances that I have suggested, I would commend Dr Jay and SA for a job well done. In my opinion, they were in no position to role the dice on the consequential damages issue. Amarex had very little hope of winning on the $14 million it claimed to be due from CYDY, for obvious reasons, but the consequential damages limit of liability issue could have gone either way and the insurance policy probably had a provision excluding intentional acts from coverage -- so SA might have had to thread the needle to obtain a finding of gross negligence in order to fall within both the public policy exception barring enforcement of the limited liability provision and the applicable insurance coverage.

Finally, you might also wonder why Amarex's insurance carrier would agree to pay out the policy limits if Amerex (and the carrier) might have prevailed on the consequential damages limitation. If the policy limits were actually $10 million (and we'll probably never know), the carrier would likely not have willingly offered the whole $10 million to protect its insured. However, in that scenario, Amarex's lawyers, if they were competent, would have threatened the carrier with a bad faith failure to settle within policy limits lawsuit for exposing its insured to an arbitration award >$100 million if no settlement were to be reached and Amarex lost on the compensatory damages issue. If found liable for bad faith under such circumstances, the carrier would have eaten the whole award.

Bear in mind that everything I have written above has been based solely on the $12 million amount, how it will be paid, my limited understanding of controlling case law on the limitation of liability issue, and and my prior experience handling, settling, and trying complex litigation. That's not enough to make my conjecture reliable. But it is plausible, and I suspect it may help to explain why 12, though far less than the 100 anticipated by some (see closing sp today), was a good number under the circumstances.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Era Redefines Media Collaboration Worldwide

Updated Category News Views 55

AI and the Changing Media Landscape Folks, let's talk about the new kid shaking up the block—artificial intelligence, yeah, AI. The 7th World Media Summit just rolled out a snazzy preview video fittingly dubbed "AI-Powered, Toward a Shared New Future." This ain't your run-of-the-mill teaser. It's a slick mix of live-action, old footage, and some AI-engineered visuals to...

Continue Reading
SpaceMap Tackles Space Traffic With AI Innovation

Updated Category News Views 150

SpaceMap Takes Aim at the Crowded Space Above You ever look up and wonder what's hurtling above our noggins? More satellites than you can shake a stick at, that's what. And don't even start me on the debris floating around. This ain't just rocket science anymore; it's a crowded dance floor, and someone's gotta manage it. Enter SpaceMap, a plucky South Korean startup that...

Continue Reading
Innovative Eyewear Powers Ahead with 51% Revenue Boost

Updated Category News Views 64

Big Gains and Bigger Moves Ahead Here's a bit of sunshine for your investment portfolio: Innovative Eyewear's third-quarter results are packing quite the punch, showing a strong 51% uptick in revenue year-over-year. If you've got a stake in NASDAQ:LUCY, pay close attention. This ain't just a flash in the pan; it's a consistent rise, marking their 13th consecutive quarter...

Continue Reading
Trimble's New Machine Control Tech Promises Big Gains

Updated Category News Views 43

Trimble's Latest Tech: A Game-Changer? The release of Trimble's MP1087 isn't just another upgrade—it's a leap forward. The folks over at Trimble decided to do some housekeeping with their machine positioning offerings, ditching separate components for a new all-in-one device. This bad boy doesn’t just promise—it delivers up to a 15% bump in uptime, even when...

Continue Reading
Greenberg Traurig Expands Franchise Team with Tuneski

Updated Category News Views 87

DC’s Legal Landscape Shifts with Tuneski’s Move Greenberg Traurig's Washington, D.C., office just dialed it up a notch by bringing in Alexander Tuneski. A guy like this crossing the floor from DLA Piper is big news. This isn’t just any legal bean counter; with over 20 years under his belt, Tuneski knows franchise law like the back of his hand. And when you've been...

Continue Reading
Navigating Simultaneous Home Buy and Sell Strategies

Updated Category News Views 42

Juggling Two Housing Transactions You ever tried juggling chainsaws? That's what buying and selling your home at the same time can feel like. Selling First: Playing It Safe Some folks swear by selling their current home first, and there's good reason. It locks in your financial windfall, giving you a clear picture of your down payment and affordability. No more guessing...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 191

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 262

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Creality's Kid-Friendly AI 3D Printer Debuts at $329

Updated Category News Views 0

Creality Unpacks mBox for Young Innovators You squint at the market to find the next big thing, and here comes Creality tossing a fancy innovation into the ring. Meet the mBox—a kid-operated, AI-driven 3D printer. This little contraption is set to spark youthful imagination, not just buzz amongst hobbyist circles. They're rolling this out on TikTok Shop from November 9...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 154

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading

Top 5 Most Recently Viewed Articles

The Impressive Journey of RBC Bearings Stock Over 15 Years

Updated Category News Views 179

Unveiling the Growth of RBC Bearings RBC Bearings has shown a remarkable performance in the stock market over the last 15 years, outperforming the market by 6.2% annually. This impressive annualized return of 18.41% equates to a significant compound growth for shareholders. The Magnitude of Investment Returns For those investors who bought $1000 worth of RBC Bearings...

Continue Reading
Neugebauer's Town Hall: Fermi's Future Under Scrutiny

Updated Category News Views 32

Fermi's Shareholders Demand Answers: The Stage is Set There's nothing like an impending webinar showdown to light a fire under Fermi's management. Toby Neugebauer, who's not just any co-founder but the largest shareholder, is gearing up to host a Town Hall this June 30th. The absence of the Perrys—Rick and his son Griffin—is glaring, but that’s not stopping...

Continue Reading
Jeff Cook Real Estate Launches Innovative Home-Buying App

Updated Category News Views 105

Introducing a Game-Changing Real Estate App Jeff Cook Real Estate LPT Realty is transforming the home-buying experience with the launch of its innovative mobile app. This cutting-edge technology aims to enhance the way home buyers and sellers interact with the real estate market in South Carolina and North Carolina, emphasizing the company's commitment to superior...

Continue Reading
Middlefield Canadian Income PCC Sees Positive NAV Growth Trend

Updated Category News Views 160

Understanding the Net Asset Value of Middlefield Canadian Income PCC The exciting world of investment trusts often revolves around the performance of their net asset values (NAV). Middlefield Canadian Income PCC is no exception. With a focus on providing value to its investors, the company's NAV reflects its current standing in the market. Net Asset Value Insights As of a...

Continue Reading
Expanding Affordable Insulin Options Through Collaboration

Updated Category News Views 207

Enhancing Diabetes Care with New Insulin Collaboration Additional treatment options for the 38.4 million U.S. patients living with diabetes Biocon Biologics Ltd., a leading global biosimilars company, has expanded its collaboration with Civica, Inc. to introduce a new Insulin Glargine medicine. This innovative product aims to improve access to high-quality and affordable...

Continue Reading